ICD/CRT-D Lead Market Assessment
A Survey of Fifty-One Electrophysiologists
Price $2500
Deliverable: Survey with Key Findings.
Study Description:
|
Topic |
|
|
Respondent Type |
Physicians |
|
Specialties Covered |
Electrophysiologists |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website Duration: 20 minutes Size: 51 respondents Fielding Dates: February 14th to February 25th 2008 |
Objectives:
To understand electrophysiologists’ perceptions and usage of ICD/CRT-D (implantable cardioverter defibrillator/cardiac resynchronization therapy device & defibrillation) leads.
§ Assess the current market and estimate the growth in the number of ICD/CRT-D procedures over the next two years.
§ Determine the current and future use of ICD/CRT-D leads from various manufacturers.
§ Gauge the impact of Medtronic Sprint Fidelis recall in general and on 7 French ICD leads, specifically.
§ Evaluate electrophysiologists’ perceptions of product differentiation among ICDs with remote monitoring.
§ Determine the current and future use of ICDs with remote monitoring from various manufacturers.
Companies mentioned in this report:
|
Company |
Ticker Symbol |
|
Medtronic |
MDT |
|
St. Jude Medical |
STJ |
|
Boston Scientific Corp. |
BSX |
|
Biotronik |
[Private] Limited coverage |
|
Sorin |
SRN Limited coverage |
Inclusion Criteria and Respondent Demographics
|
Inclusion Criteria |
§ US-based Electrophysiologists § Board-certified/board eligible in specialty § 2 to 30 years of experience post-training § Minimum of 75% professional time spent in clinical practice § Perform at least 10 ICD/CRT-D implants per month |
To purchase this report or request additional information, contact:
Print Abstract
For additional information on this study or to purchase, please call:
|
Survey
Cardiology |